SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pbio.3001531
Publication URI: http://dx.doi.org/10.1371/journal.pbio.3001531
Type: Journal Article/Review
Parent Publication: PLOS Biology
Issue: 2